Sandbox: Difference between revisions
Jump to navigation
Jump to search
| Line 54: | Line 54: | ||
| '''Thrombocytopenia''' <br> Compare the highest platelet count within the sequence of declining platelet counts with the lowest count to determine the % of platelet fall. <br> (Select only 1 option) | | '''Thrombocytopenia''' <br> Compare the highest platelet count within the sequence of declining platelet counts with the lowest count to determine the % of platelet fall. <br> (Select only 1 option) | ||
| > 50% platelet fall AND nadir of ≥ 20 AND no surgery within preceding 3 days | | > 50% platelet fall AND nadir of ≥ 20 AND no surgery within preceding 3 days | ||
| > 50% platelet fall BUT surgery within preceding 3 days OR <br> any combination of platelet fall and nadir that does not fit criteria for score 2 or score 0 (eg. 30-50% platelet fall or nadir 10-19) | | > 50% platelet fall BUT surgery within preceding 3 days OR <br> any combination of platelet fall and nadir that does not fit criteria for score 2 or score 0 (eg. 30-50% platelet fall or nadir 10-19) | ||
| Line 62: | Line 61: | ||
|- | |- | ||
| | | '''Timing (of platelet count fall or thrombosis)''' <br> Day 0 = first day of most recent heparin exposure (Select only 1 option) | ||
| | | platelet fall day 5-10 after start of heparin <br> platelet fall within 1 day of start of heparin AND exposure to heparin within past 5-30 days | ||
| | | consistent with platelet fall days 5-10 but not clear (eg. missing counts) <br> platelet fall within 1 day of start of heparin AND exposure to heaprin in past 31-100 days <br> platelet fall after day 10 | ||
| | | platelet fall ≤ day 4 without exposure to heaprin in pas 100 days | ||
|- | |- | ||
| | | '''Thrombosis (or other clinical sequelae)''' <br> (Select only 1 option) | ||
| | | confirmed new thrombosis (venous or arterial) <br> skin necrosis at injection site <br> anaphylactoid reaction to IV heparin bolus <br> adrenal hemorrhage | ||
| | | recurrent venous thrombosis in a patient receiving therapeutic anticoagulants <br> suspected thrombosis (awaiting confirmation with imaging) <br> erythematous skin lesions at he heparin onjection sites | ||
| | | thrombosis suspected | ||
|- | |- | ||
|} | |||
Revision as of 17:31, 2 January 2014
| Mild DKA | Moderate DKA | Severe DKA | HHS | |
| Plasma glucose | >250 mg/dL | >250 mg/dL | >250 mg/dL | >600 mg/dL |
| Arterial pH | 7.25-7.30 | 7.00 to <7.24 | <7.00 | >7.30 |
| Serum bicarbonate (mEq/l) | 15-18 | 10 to <15 | <10 | >18 |
| Urine ketone | Positive | Positive | Positive | Small |
| Serum ketone | Positive | Positive | Positive | Small |
| Effective serum osmolality | Variable | Variable | Variable | >320 mOsm/kg |
| Anion gap | >10 | >12 | >12 | Variable |
| Mental status | Alert | Alert/drowsy | Stupor/coma | Stupor/coma |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
table HIT
| Score = 2 | Score = 1 | Score = 0 | |
|---|---|---|---|
| Thrombocytopenia Compare the highest platelet count within the sequence of declining platelet counts with the lowest count to determine the % of platelet fall. (Select only 1 option) |
> 50% platelet fall AND nadir of ≥ 20 AND no surgery within preceding 3 days | > 50% platelet fall BUT surgery within preceding 3 days OR any combination of platelet fall and nadir that does not fit criteria for score 2 or score 0 (eg. 30-50% platelet fall or nadir 10-19) |
< 30% platelet fall any platelet fall with nadir < 10 |
| Timing (of platelet count fall or thrombosis) Day 0 = first day of most recent heparin exposure (Select only 1 option) |
platelet fall day 5-10 after start of heparin platelet fall within 1 day of start of heparin AND exposure to heparin within past 5-30 days |
consistent with platelet fall days 5-10 but not clear (eg. missing counts) platelet fall within 1 day of start of heparin AND exposure to heaprin in past 31-100 days platelet fall after day 10 |
platelet fall ≤ day 4 without exposure to heaprin in pas 100 days |
| Thrombosis (or other clinical sequelae) (Select only 1 option) |
confirmed new thrombosis (venous or arterial) skin necrosis at injection site anaphylactoid reaction to IV heparin bolus adrenal hemorrhage |
recurrent venous thrombosis in a patient receiving therapeutic anticoagulants suspected thrombosis (awaiting confirmation with imaging) erythematous skin lesions at he heparin onjection sites |
thrombosis suspected |